Notice of Intent To Grant An Exclusive License, 15263 [E6-4326]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 58 / Monday, March 27, 2006 / Notices
The agenda will include the following:
Various IRS issues.
Dated: March 21, 2006.
John Fay,
Acting Director, Taxpayer Advocacy Panel.
[FR Doc. E6–4331 Filed 3–24–06; 8:45 am]
BILLING CODE 4830–01–P
DEPARTMENT OF THE TREASURY
Internal Revenue Service
Open Meeting of the Earned Income
Tax Credit Committee of the Taxpayer
Advocacy Panel
Internal Revenue Service (IRS),
Treasury.
ACTION: Notice.
AGENCY:
An open meeting of the
Earned Income Tax Credit Committee of
the Taxpayer Advocacy Panel will be
conducted at the Internal Revenue
Service, 1111 Constitution Avenue,
NW., Washington, DC 20224, in Room
7718. The Committee will be discussing
issues pertaining to the IRS
administration of the Earned Income
Tax Credit.
DATES: The meeting will be held Friday,
April 21, 2006, from 9 a.m. through 12
noon ET.
FOR FURTHER INFORMATION CONTACT:
Audrey Y. Jenkins at 1–888–912–1227
(toll-free), or 718–488–2085 (non tollfree).
SUMMARY:
Notice is
hereby given pursuant to Section 10(a)
(2) of the Federal Advisory Committee
Act, 5 U.S.C. App. (1988) that an open
meeting of the Earned Income Tax
Credit Committee of the Taxpayer
wwhite on PROD1PC65 with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Aug<31>2005
20:32 Mar 24, 2006
Jkt 208001
Advocacy Panel will be held Friday,
April 21, 2006 from 9 a.m. to 12 p.m.
ET at 1111 Constitution Avenue, NW.,
Washington, DC 20224, Room 7718. The
public is invited to make oral
comments. Individual comments will be
limited to 5 minutes. For information or
to confirm attendance, contact Audrey
Y. Jenkins as noted above. Notification
of intent to participate in the meeting
must be made with Ms. Jenkins. If you
would like a written statement to be
considered, send written comments to
Ms. Audrey Y. Jenkins, TAP Office, 10
MetroTech Center, 625 Fulton Street,
Brooklyn, NY 11201 or post your
comments to the Web site: https://
www.improveirs.org. The agenda will
include various IRS issues.
Dated: March 21, 2006.
John Fay,
Acting Director, Taxpayer Advocacy Panel.
[FR Doc. E6–4341 Filed 3–24–06; 8:45 am]
BILLING CODE 4830–01–P
DEPARTMENT OF VETERANS
AFFAIRS
Notice of Intent To Grant An Exclusive
License
Office of Research and
Development, Department of Veterans
Affairs.
ACTION: Notice of intent.
AGENCY:
SUMMARY: Notice is hereby given that
the Department of Veterans Affairs,
Office of Research and Development,
intends to grant to New England
Compounding Pharmacy, Inc., 697
Waverly Street, Framingham, MA 01701
an exclusive license to practice U.S.
Patent No. 6,569,615 issued, May 27,
PO 00000
Frm 00107
Fmt 4703
Sfmt 4703
15263
2003, entitled, ‘‘Compositions and
Methods for Tissue Preservation.’’
DATES: Comments must be received by
April 11, 2006.
ADDRESSES: Send comments to: Amy E.
Centanni, Director of Technology
Transfer, Department of Veterans
Affairs; Office of Research and
Development Attn: 12TT; 810 Vermont
Avenue, NW., Washington, DC 20420.
Telephone: (202) 254–0199; Facsimile:
(202) 254–0473; e-mail:
amy.centanni@mail.va.gov.
FOR FURTHER INFORMATION CONTACT:
Copies of the published patent may be
obtained from the U.S. Patent and
Trademark Office at https://
www.uspto.gov.
It is in the
public interest to license this invention
as New England Compounding
Pharmacy, Inc., submitted a complete
and sufficient application for a license.
The prospective exclusive license will
be royalty-bearing and will comply with
the terms and conditions of 35 U.S.C.
209 and 37 CFR 404.7. The prospective
exclusive license may be granted unless,
within fifteen (15) days from the date of
this published Notice, the Department
of Veterans Affairs, Office of Research
and Development receives written
evidence and argument which
establishes that the grant of the license
would not be consistent with the
requirements of 35 U.S.C. 209 and 37
CFR 404.7.
SUPPLEMENTARY INFORMATION:
Approved: March 17, 2006.
Gordon H. Mansfield,
Deputy Secretary of Veterans Affairs.
[FR Doc. E6–4326 Filed 3–24–06; 8:45 am]
BILLING CODE 8320–01–P
\\ALPHA3\E\FR\FM\27MRN1.SGM
27MRN1
]]>Agencies
[Federal Register Volume 71, Number 58 (Monday, March 27, 2006)]
[Notices]
[Page 15263]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-4326]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF VETERANS AFFAIRS
Notice of Intent To Grant An Exclusive License
AGENCY: Office of Research and Development, Department of Veterans
Affairs.
ACTION: Notice of intent.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that the Department of Veterans
Affairs, Office of Research and Development, intends to grant to New
England Compounding Pharmacy, Inc., 697 Waverly Street, Framingham, MA
01701 an exclusive license to practice U.S. Patent No. 6,569,615
issued, May 27, 2003, entitled, ``Compositions and Methods for Tissue
Preservation.''
DATES: Comments must be received by April 11, 2006.
ADDRESSES: Send comments to: Amy E. Centanni, Director of Technology
Transfer, Department of Veterans Affairs; Office of Research and
Development Attn: 12TT; 810 Vermont Avenue, NW., Washington, DC 20420.
Telephone: (202) 254-0199; Facsimile: (202) 254-0473; e-mail:
amy.centanni@mail.va.gov.
FOR FURTHER INFORMATION CONTACT: Copies of the published patent may be
obtained from the U.S. Patent and Trademark Office at https://
www.uspto.gov.
SUPPLEMENTARY INFORMATION: It is in the public interest to license this
invention as New England Compounding Pharmacy, Inc., submitted a
complete and sufficient application for a license. The prospective
exclusive license will be royalty-bearing and will comply with the
terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective
exclusive license may be granted unless, within fifteen (15) days from
the date of this published Notice, the Department of Veterans Affairs,
Office of Research and Development receives written evidence and
argument which establishes that the grant of the license would not be
consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7.
Approved: March 17, 2006.
Gordon H. Mansfield,
Deputy Secretary of Veterans Affairs.
[FR Doc. E6-4326 Filed 3-24-06; 8:45 am]
BILLING CODE 8320-01-P
